|
Number of respondents
|
25
|
|
Role
|
|
Medical oncologist
|
16 (64%)
|
|
Oncology pharmacist
|
9 (36%)
|
|
Mean age, years (range)
|
41.2 (28–67)
|
|
Sex
|
|
Male
|
11 (44%)
|
|
Female
|
14 (56%)
|
|
Race
|
|
Non-Hispanic White
|
18 (72%)
|
|
Asian
|
7 (28%)
|
|
Mean time in practice, years (range) a
|
10.2 (0.5–35)
|
|
Comfort with interpreting PGx test results
|
|
Comfortable or very comfortable
|
15 (60%)
|
|
Neutral
|
3 (12%)
|
|
Uncomfortable or very uncomfortable
|
7 (28%)
|
|
Comfort with using PGx test results to guide chemotherapy dosing
|
|
Comfortable or very comfortable
|
14 (56%)
|
|
Neutral
|
4 (16%)
|
|
Uncomfortable or very uncomfortable
|
7 (28%)
|
|
Mean interview duration, minutes (range)
|
30.3 (23–41)
|
|
Interview modality
|
|
In-person
|
14 (56%)
|
|
Telephone
|
11 (44%)
|
